community pharmacy flu vaccination services- preparing for 2014/15
Post on 19-Feb-2016
39 Views
Preview:
DESCRIPTION
TRANSCRIPT
Community pharmacy flu vaccination services- preparing for 2014/15
The national flu programme
Jo Yarwood Programme Manager - Immunisation
Public Health England
Vaccine uptake since 200065 and over (under 65 ‘at risk’)
Year England (%) Scotland (%) Wales (%) Northern Ireland (%)
2000–01 65.4 65 39 68
2001–02 67.5 65 59 72
2002–03 68.6 69 54 72.1 (55.8)
2003–04 71.0 72.5 63 73.4 (63.8)
2004–05 71.5 (39.9) 71.7 (39.3) 63 72.7 (65.2)
2005–06 75.3 (48.0) 77.8 (46.3) 68 76.8 (80.9)
2006–07 73.9 (42.1) 75.2 (37.8) * 75.1 (71.2)
2007–08 73.5 (45.3) 74.3 (44.4) 64 75.7 (68.3)
2008–09 74.1 (47.1) 76.3 (47.8) 60 (41) 76.8 (74.0)
2009–10 72.4 (51.6) 75.0 (53.4) 64 (49) 77.0 (80.0)
2010–11 72.8 (50.4) 75.3 (56.1) 65.8 (48.6) 74.9 (78.7)
2011-12 74.0 (51.6) 76.6 (59.7)** 67.7 (50.0) 77.0 (81.7)
2012-13 73.4 (51.3) 76.5 (55.9) 67.7 (49.7) 75.0 (80.2)
3
Flu uptakeYear 2012/13 2013/14
65 and over 73.4% 73.2%
Under 65 at risk 51.3% 52.3%
Pregnant women 40.3% 39.8%
All 2 year olds n/a 42.6%
All 3 year olds n/a 39.6%
HCW 45.9% 54.8%
4
Getting vaccinated in pharmacies• 89K people got the jab at Boots
• just over 20% of these were in a risk group
• they could therefore have got a free NHS jab.
• processes should be in place for GP records to be updated
• do these immunisations go unrecorded on GP systems?
• it may be that the official vaccine uptake figures produced, particularly for the under 65 at risks who are more likely to be in employment and less likely to see their GP, underestimate the true vaccine uptake figures.
• http://www.pjonline.com/news/research_highlights_opportunity_for_pharmacy_to_fill_gap_in_flu_vaccinations?
5
The risk of the risk groups Number of fatal flu cases
(%)Mortality rate per 100,000 population
Age-adjusted relative risk*
In a risk group 213(59.8)
4.0 11.3(9.1-14.0)
Not in any risk group 143(40.2)
0.4 Baseline
Chronic renal disease 19 (5.3)
4.8 18.5
Chronic heart disease 32 (9.0) 3.7 10.7(7.3-15.7)
Chronic respiratory disease 59(16.6)
2.4 7.4(5.5-10.0)
Chronic liver disease 32 (9.0)
15.8 48.2(32.8-70.6)
Diabetes 26 (7.3)
2.2 5.8(3.8-8.9)
Immunosuppression 71(19.9)
20.0 47.3(35.5-63.1)
Chronic neurological disease (excluding stroke/transient ischaemic attack)
42(11.8)
14.7 40.4(28.7-56.8)
Total (including 22 cases with no information on clinical risk factors)
378 0.8
6
Health care workers
7
8
Vaccine uptake in all pregnant women
Year England (%) Scotland (%) Wales (%) Northern Ireland (%)
2010-11 38.0 65.6* 39.6 N/A2011-12 27.4 41.1 31.7 58.42012-13 40.3 54.0 61.6 64.6
9
10
So, what’s new?
11
Flu programme extension
Aim to offer annual vaccination for all children age 2-16 2013/14 Routine 2 and 3 yr olds Pilot yrs 0 - 6
Potential plan for next three years – 2014/15 Routine 2,3 and 4 yr olds Pilot yrs 0 – 6 &
7 & 82015/16 Extend where indicated2016/17 Extend where indicated and then
?JCVI assessment
12
Pilot sites and uptakeSite Cohort Vaccinated % Uptake
Bury 16773 10528 62.8
Cumbria 36289 13528 37.3
Gateshead 14895 7784 52.3
Havering 20545 13408 65.3
Leicester 54966 28600 52.0
Newham 30730 14207 46.2
SE Essex 24723 17509 70.8
Total 198921 105564 53.1
What went well?• Well accepted by children• Well accepted by parents• Schools collaborated well• Nurses enjoyed working with the children• Pharmacists as joint providers• Self administration
14
What was hard?• Administrative burden (consent, screening for high risk etc.)• Generally hard work• Workforce capacity• Working across boundaries• Porcine gelatine
15
What vaccine should be used?Vaccine type Authorised age
indicationDose
Live attenuated intranasal vaccine - Fluenz®
Children aged two to under 18 years (see precautions and contraindications)
Single application in each nostril of 0.1ml
Children NOT in clinical risk groups only require one dose of this vaccine.
Children in clinical risk groups aged two to under nine years who have not received influenza vaccine before should receive a second dose of vaccine at least four weeks later.
Inactivated intramuscular vaccine (number of different brands)
Children aged six months and older and adults, although some of the vaccines are not authorised for young children – see table 19.6
Single injection of 0.5ml (see note above)
Children aged six months to under nine years who have not received influenza vaccine before should receive a second dose of vaccine at least four weeks later.
Inactivated intradermal vaccine - Intanza® 9µg
Adults aged 18 years to 59 years
Single injection of 0.1ml
Inactivated intradermal vaccine - Intanza® 15µg
Adults aged 60 years and older
Single injection of 0.1ml
16
17
Acknowledge - EVERYBODY
top related